Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ESPEROCT ® safely and effectively. See full prescribing information for ESPEROCT. ESPEROCT [antihemophilic factor (recombinant), glycopegylated-exei]lyophilized powder for solution, for intravenous use Initial U.S. Approval: 2019
Medication labelWhy this: Advisory · dailymed-other
ESPEROCT [antihemophilic factor (recombinant), glycopegylated-exei] is a recombinant DNA-derived coagulation Factor VIII concentrate indicated for use in adults and children with hemophilia A for: •On-demand treatment and control of bleeding episodes •Perioperative management of bleeding •Routine prophylaxis to reduce the frequency of bleeding episodes Limitation of Use: ESPEROCT is not indicated for the treatment of von Willebrand disease.
- generic_name
- antihemophilic factor (recombinant), glycopegylated-exei
- brand_name
- Sodium chloride solution
- product_names
- antihemophilic factor (recombinant), glycopegylated-exei, Sodium chloride solution
- ndc
- 0169-8008, 0169-8500, 0169-8500-01, 0169-8500-93, 0169-8501, 0169-8501-11, 0169-8501-90, 0169-8008-98, 0169-8100, 0169-8100-01, 0169-8100-93, 0169-8101, 0169-8101-11, 0169-8101-90, 0169-8150, 0169-8150-01, 0169-8151, 0169-8151-11, 0169-8200, 0169-8200-01, 0169-8201, 0169-8201-11, 0169-8300, 0169-8300-01, 0169-8300-93, 0169-8301, 0169-8301-11, 0169-8301-90, 0169-8400, 0169-8400-01, 0169-8401, 0169-8401-11, 0169-8055, 0169-8055-01, 0169-8051, 0169-8051-11
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en